Skip to content

Impact of Branched-chain Amino Acids in the Development of Insulin Resistance

Branched-Chain Amino Acid Dietary Reduction Under Weight Maintainance in Overweight Patients With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03261362
Acronym
BRAAWO
Enrollment
12
Registered
2017-08-25
Start date
2016-03-31
Completion date
2019-12-31
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study is to clarify the role of the branched-chain amino acids in the development of Insulin resistance in patients with diabetes

Detailed description

The proposed project aims to elucidate the role of the BCAA in the development of insulin resistance and type 2 diabetes. The project tests the hypothesis that a diet induced decrease of BCAAs concentrations alter the metabolic mechanisms involved in the control insulin resistance and diabetes progression. The specific aims are to elucidate the effect of the diet induced decrease of BCAAs concentrations on (I) peripheral and hepatic insulin sensitivity (II) ectopic fat distribution (III) energy metabolism (IV) metabolic and inflammatory status

Interventions

DIETARY_SUPPLEMENTBranched-chain amino acids reduced intake

Sponsors

German Diabetes Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Diabetes type 2 * Non smokers * Untrained * Willingness to adhere to a diet intervention

Exclusion criteria

* Chronic disease * Pregnancy * Cancer * Antibiotic therapy * Drug/alcohol abuse * Competitive athletes

Design outcomes

Primary

MeasureTime frameDescription
Clamp testup to 24 weeksInsulin sensitivity test

Secondary

MeasureTime frameDescription
Mixed Meal Testup to 24 weeksB cell function test

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026